Cynthia L. Feldmann was appointed to our board of directors in September 2020. Ms. Feldmann is an experienced finance and accounting professional who brings several decades of experience in life sciences and public company board leadership to Frequency. She was a partner at KPMG LLP from 1994 to 2002, where she held leadership roles in the firm’s medical technology and health care and life sciences industry groups and was the lead partner in the life sciences practice for Coopers & Lybrand (now PricewaterhouseCoopers LLP) during her 19-year career there (from 1975 to 1994). Currently, she is a member of the board of directors at STERIS PLC (NYSE: STE), where she has served since 2005, and at UFP Technologies (NASDAQ: UFPT), where she has served since 2017. She has also served as a director at Atrius Health (2012-2013), Hanger Inc. (NYSE: HNGR), a provider of orthotic and prosthetic services and products (2003-2018) and Heartware International, Inc., a medical device company that was acquired by Medtronic (2012-2016). Ms. Feldmann earned her B.S. in accounting from Boston College and holds a Master Professional Director Certification from the American College of Corporate Directors.